Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sectra ABCHIX:SECTBS 98 EV-to-EBIT is 72.18 as of Jul. 18, 2026, which is 14% above its 10-year median of 63.39. GuruFocus rates CHIX:SECTBS with a GF Score™ of 98/100 and a GF Value™ of kr310.37 (Modestly Undervalued). Among 466 Medical Devices & Instruments companies, Sectra AB ranks worse than 91.42% on this metric.
The historical rank and industry rank for Sectra AB's EV-to-EBIT or its related term are showing as below:
CHIX:SECTBs'
s EV-to-EBIT Range Over the Past 10 Years
Min: 23.24 Med: 63.39 Max: 116.55
Current: 72.18
During the past 13 years, the highest EV-to-EBIT of Sectra AB was 116.55. The lowest was 23.24. And the median was 63.39.
CHIX:SECTBs's EV-to-EBIT is ranked worse than 91.42% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 18.46
vs CHIX:SECTBs: 72.18
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Sectra AB's Enterprise Value for the quarter that ended in Apr. 2026 was kr49,942 Mil.
Sectra AB's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr711 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sectra AB EV-to-EBIT Related Terms
Sectra AB EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Sectra AB's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:SECTBS vs ABT, SYK, MDT: EV-to-EBIT Comparison
For the Medical Devices subindustry, Sectra AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sectra AB EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sectra AB's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Sectra AB's EV-to-EBIT falls into.
Sectra AB's current Enterprise Value is kr51,291 Mil.
Sectra AB's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr711 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sectra AB (CHIX:SECTBS) has a EV-to-EBIT of 72.18 as of Jul. 18, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Sectra AB and its competitors. This is 14% above median its historical median of 63.39. Over the past decade, Sectra AB's EV-to-EBIT has ranged from 23.24 to 116.55. According to the industry distribution chart, Sectra AB ranks #426 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 91.4%.
Is Sectra AB's EV-to-EBIT too high?
Sectra AB's current EV-to-EBIT of 72.18 is 14% above median its 10-year median of 63.39. Over the past 10 years, this metric has ranged from a low of 23.24 to a high of 116.55. The Medical Devices & Instruments industry median EV-to-EBIT is 18.46. Sectra AB's value of 72.18 is 291% above this industry median. Based on the distribution chart, Sectra AB ranks #426 out of 466 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sectra AB has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sectra AB ranks #426 out of 466 companies for EV-to-EBIT. This places Sectra AB in the lower half of its industry. The industry median EV-to-EBIT is 18.46. Sectra AB's value of 72.18 is 291% above this benchmark. Historically, Sectra AB's own EV-to-EBIT has ranged from 23.24 to 116.55 over the past decade. While the company's 10-year median is 63.39 vs. the industry median of 18.46, Sectra AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.46, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sectra AB's current EV-to-EBIT of 72.18 is 291% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Sectra AB and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sectra AB's current EV-to-EBIT is 72.18, which is 14% above median its own 10-year median of 63.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (CHIX:SECTBS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr310.37, compared to a current price of kr277.30 — trading 10.7% below its estimated fair value. The current EV-to-EBIT is 72.18, which is 14% above median its 10-year median of 63.39 and 291% above the Medical Devices & Instruments industry median of 18.46. Sectra AB's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Sectra AB (CHIX:SECTBS), the current EV-to-EBIT is 72.18 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sectra AB (CHIX:SECTBS) Overvalued in 2026?
Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued.
The current stock price of kr277.30 is trading 10.7% below its estimated GF Value™ of kr310.37.
GuruFocus considers Sectra AB to be Modestly Undervalued.
Key valuation signals for CHIX:SECTBS:
EV-to-EBIT: 72.18 (14% above median its 10-year median of 63.39)
GF Value™: kr310.37 vs. price of kr277.30 (10.7% below fair value)
Industry Position: 291% above the Medical Devices & Instruments median (#426 of 466)
No single metric tells the full story. See the CHIX:SECTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
98GF Score
Get the complete analysis for CHIX:SECTBS
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SECTBS has been successfully added to your 
